Antileishmanial activity of quinazoline derivatives: Synthesis, docking screens, molecular dynamic simulations and electrochemical studies

European Journal of Medicinal Chemistry
2015.0

Abstract

A series of quinazoline-2,4,6-triamine were synthesized and evaluated in vitro against Leishmania mexicana. Among them, N(6)-(ferrocenmethyl)quinazolin-2,4,6-triamine (H2) showed activity on promastigotes and intracellular amastigotes, as well as low cytotoxicity in mammalian cells. Docking and electrochemical studies showed the importance of both the ferrocene and the heterocyclic nucleus to the observed activity. H2 is readily oxidized electrochemically, indicating that the mechanism of action probably involves redox reactions.

Knowledge Graph

Similar Paper

Antileishmanial activity of quinazoline derivatives: Synthesis, docking screens, molecular dynamic simulations and electrochemical studies
European Journal of Medicinal Chemistry 2015.0
4-Arylamino-6-nitroquinazolines: Synthesis and their activities against neglected disease leishmaniasis
European Journal of Medicinal Chemistry 2016.0
Design, synthesis and biological evaluation of quinazoline derivatives as anti-trypanosomatid and anti-plasmodial agents
European Journal of Medicinal Chemistry 2015.0
Antileishmanial Activity of a Series of N<sup>2</sup>,N<sup>4</sup>-Disubstituted Quinazoline-2,4-diamines
Journal of Medicinal Chemistry 2014.0
Design and synthesis of novel substituted quinazoline derivatives as antileishmanial agents
Bioorganic &amp; Medicinal Chemistry Letters 2009.0
Identification of 2-arylquinazolines with alkyl-polyamine motifs as potent antileishmanial agents: synthesis and biological evaluation studies
RSC Medicinal Chemistry 2022.0
Antileishmanial activity of new hybrid tetrahydroquinoline and quinoline derivatives with phosphorus substituents
European Journal of Medicinal Chemistry 2019.0
Anti-leishmanial evaluation of C2-aryl quinolines: Mechanistic insight on bioenergetics and sterol biosynthetic pathway of Leishmania braziliensis
Bioorganic &amp; Medicinal Chemistry 2013.0
Antitumor and antileishmanial evaluation of novel heterocycles derived from quinazoline scaffold: a molecular modeling approach
Medicinal Chemistry Research 2013.0
Antileishmanial pharmacomodulation in 8-nitroquinolin-2(1H)-one series
Bioorganic &amp; Medicinal Chemistry 2015.0